The 2025 Nobel Prize in Medicine Explained: How Your Immune System's Peacekeepers Prevent Self-Destruction.
- Dr Audrey-Flore Ngomsik
- Oct 14
- 6 min read
How three pioneering scientists uncovered the secret behind autoimmune diseases, and what it means for our future.
Our immune system is one of the most sophisticated defense mechanisms ever evolved. It’s like a highly trained security team, constantly on alert for threats like bacteria, viruses, or even cancer.
But what happens when that security team goes rogue and starts attacking the very people it’s meant to protect?
That’s the question scientists have been struggling with for years.
And this week, the Nobel Prize in Medicine provided an answer that could change the way we understand diseases like autoimmune disorders, conditions where the immune system mistakenly attacks the body’s own tissues.
The 2025 Nobel Prize in Medicine was awarded to Shimon Sakaguchi, Mary E. Brunkow, and Fred Ramsdell for their groundbreaking discovery of how the immune system prevents this from happening, which also has profound implications for the future of medicine and even our planet’s health.[1]
The scientist who proved everyone wrong
In 1995, the scientific accepted knowledge was that the immune system learned tolerance through a simple process: Any immune cell that wanted to attack "you" got eliminated in the thymus (an organ behind your breastbone) during development. Done. Problem solved.
This was called central tolerance, and everyone was pretty comfortable with this explanation.
Sakaguchi looked at this and though that can't be the whole story.
And he was right.
He discovered the immune system has its own security team, regulatory T cells. They ensure the body’s defense forces don’t turn on themselves. These “bouncers” patrol your body, keeping the immune system in check. Without them, your immune system would behave like a wild vigilante, attacking anything that looks suspicious, even your own organs.
Think of it this way:
The old theory said your body just doesn't hire security guards who might shoot the guests. Sakaguchi proved that your body actually does hire those guards, but then assigns other guards to follow them around and tackle them if they get trigger-happy.
It's surveillance on your surveillance. It's what is called the immune system inception.
So, what happens when these regulatory cells fail?
Without functional regulatory T cells, your immune system becomes a vigilante with no supervision, attacking anything that looks suspicious, including your own organs.
Diseases like rheumatoid arthritis, type 1 diabetes, and multiple sclerosis are all examples of autoimmune conditions where the immune system mistakenly targets its own tissues, causing inflammation and damage.
One of the most severe forms of this is Systemic Lupus Erythematosus, a disease where the immune system attacks everything from joints to skin to organs like the heart and kidneys.
A key breakthrough
This year’s Nobel Prize-winning research centers around the discovery of regulatory T cells and their vital role in preventing this type of self-destruction.
Mary Brunkow and Fred Ramsdell were studying mice that kept developing terrible autoimmune diseases. These mice were basically allergic to themselves.
They found the culprit: a mutated gene they named Foxp3.
When this gene doesn't work, regulatory T cells don't develop properly. And when that happens?
Total chaos happens.
The immune system attacks everything. It turns against the body, leading to autoimmune disorders.
The implications of this are huge. By understanding how to enhance or restore the function of these regulatory cells, scientists are developing potential therapies for autoimmune diseases.
For example, in diseases like type 1 diabetes, where the immune system attacks insulin-producing cells in the pancreas, this discovery could eventually lead to treatments that restore balance and prevent this self-destructive behavior.
They also discovered that humans with mutations in this gene develop IPEX, a devastating autoimmune disease that can affect multiple organs.
Imagine a city where all the police officers quit. That's what happens when Foxp3 doesn't work. Your immune system becomes a riot.
The connection that won the Nobel
In 2003, Sakaguchi connected the dots. He proved that the Foxp3 gene is the master control switch for regulatory T cells. It's what tells these cells to develop and do their job.
This was the breakthrough.
what it quite rightly identifies asSuddenly, scientists understood:
What keeps the immune system in check (regulatory T cells)
How these cells develop (the Foxp3 gene)
Why some people develop autoimmune diseases (Foxp3 mutations)
It's like finding not just the murder weapon, but also the killer and their motive.
Why should you care? (Besides the whole "Not dying" thing)
Here's where this gets really exciting, and why this isn't just purely academic exercise.
Understanding regulatory T cells has launched an entire field of medicine.
We're talking:
Cancer treatments that remove the brakes from your immune system so it can attack tumors
Autoimmune disease therapies that strengthen the regulatory T cells to calm down overactive immunity
Better organ transplants by teaching the immune system to tolerate what it quite rightly identifies as foreign tissue
Multiple treatments currently in clinical trials
The conventional wisdom in medicine used to be:
suppress the entire immune system (steroids) or
boost the entire immune system (early immunotherapy).
This discovery showed us we can target specific parts of the immune system. We can boost the parts we need and calm down the parts causing problems.
The truth about scientific breakthroughs
Here's what strikes us as a CSR strategist: 2025's Nobel Prizes tell the same story three times over.
Medicine: Sakaguchi discovered regulatory T cells in 1995. The scientific community told him he was wrong. Everyone "knew" that immune tolerance happened only in the thymus. Brunkow and Ramsdell found the Foxp3 gene in 2001. Sakaguchi connected them in 2003. Nobel Prize: 2025.
Gap: 22-30 years.
Chemistry: Richard Robson started drilling holes in wooden balls for a chemistry lesson in 1974, sparking an idea about molecular frameworks. Susumu Kitagawa presented his first molecular construction in 1992. It wasn't particularly useful at first. Omar Yaghi developed stable metal-organic frameworks in the late 1990s. Nobel Prize: 2025.
Gap: 33-51 years.
Physics: John Clarke, Michel Devoret, and John Martinis demonstrated macroscopic quantum tunneling in superconducting circuits in 1984-1985. Clarke said
The idea it might win a Nobel "had never occurred to me.
Nobel Prize: 2025.
Gap: 40-41 years.
All three discoveries challenged conventional wisdom.
All three were dismissed, doubted, or deemed "useless" initially.
All three persisted anyway.
And all three took decades to receive recognition, even though they fundamentally changed their fields and are now saving lives, cleaning water, and powering quantum computers.
What this means for healthcare, pharma, and climate investment
If your company has any stake in R&D, whether healthcare, materials science, climate tech, or advanced computing, this should tell you something critical: The breakthroughs that challenge conventional wisdom are exactly the ones worth betting on.
Kitagawa followed a principle he learned from Nobel laureate Hideki Yukawa: to see
"the usefulness of useless."
When funders rejected his work because it "had no purpose," he kept going. Now MOFs harvest water from deserts and capture carbon from the atmosphere.
The entire field of immune checkpoint inhibitors , cancer drugs that won the 2018 Nobel Prize[2] and generate billions in revenue, builds directly on understanding regulatory T cells.
The foundation was laid in 1995. Recognition came 30 years later.
We're really bad at recognizing breakthrough innovations when they're happening.
The 2025 Nobel Prizes in Medicine, Chemistry, and Physics all honored work that's 22-51 years old. Not because the science took that long to matter, after all, these discoveries have been transforming their fields for decades; but because it takes that long for the world to fully grasp just how wrong we were before.
The moral?
The most important discoveries are often the ones that make everyone else say "wait, that can't be right" at first.
Beyond the lab: How this links to climate change
Climate change, much like autoimmune diseases, is a global system failure.
In the same way that the immune system, when unbalanced, turns against the body, the environment, when disrupted by human activity, begins to fight back.
Extreme weather events, rising sea levels, and global health crises like heat strokes or the spread of infectious diseases are the symptoms of a much larger, systemic breakdown.
Just as scientists are now focusing on restoring balance to the immune system by enhancing regulatory T cells, we need to do the same for the planet.
The groundbreaking work of the Nobel Prize winners shows that complex systems, whether biological or environmental, thrive when they maintain checks and balances.
But when those systems are out of control, the consequences are tremendous.
What can businesses do?
Adopt a systems thinking approach: Just as regulatory T cells balance the immune system, businesses can adopt a holistic, systems-based approach to sustainability. This means understanding the interconnections between climate change, biodiversity, and social welfare. It’s about recognizing that disrupting one part of the system can have ripple effects across the entire global ecosystem, much like how a malfunctioning immune system leads to autoimmune diseases.
Invest in climate solutions: By supporting scientific advancements that aim to restore ecological balance (whether through clean energy, carbon capture, or reforestation), businesses can help “calm” the environmental immune system, just as new treatments are being developed for autoimmune diseases.
Corporate Social Responsibility (CSR) and the future of health: The same principle of balance applies in CSR initiatives, companies that focus on responsible environmental practices, social equity, and ethical governance are contributing to a healthier global ecosystem. Supporting clean tech, sustainable supply chains, and renewable energy projects not only combats climate change but also supports human health by reducing air pollution, water scarcity, and the spread of diseases.
Comments